The $2.38 EPS Expected for UnitedHealth Group Inc (UNH) This Quarter

The $2.38 EPS Expected for UnitedHealth Group Inc (UNH) This Quarter

According to Zacks, analysts expect that UnitedHealth Group will report full-year earnings of $9.80 per share for the current fiscal year, with EPS estimates ranging from $9.75 to $9.85. For the next year, analysts anticipate that the firm will post earnings of $10.75 per share, with EPS estimates ranging from $10.67 to $11.00. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that that provide coverage for UnitedHealth Group.

Equities analysts forecast that UnitedHealth Group Inc (NYSE:UNH) will report earnings per share (EPS) of $2.38 for the current quarter, Zacks Investment Research reports. Seven analysts have issued estimates for UnitedHealth Group’s earnings. The highest EPS estimate is $2.41 and the lowest is $2.35. UnitedHealth Group posted earnings of $1.96 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 21.4%. The firm is scheduled to announce its next earnings report on Tuesday, July 18th.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. The company had revenue of $48.72 billion for the quarter, compared to analyst estimates of $48.21 billion. During the same quarter in the prior year, the firm posted $1.81 EPS. UnitedHealth Group’s quarterly revenue was up 9.4% compared to the same quarter last year. A number of brokerages recently commented on UNH. Cantor Fitzgerald reiterated an “overweight” rating and set a $205.00 price objective (up previously from $200.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Vetr downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 price objective on the stock. in a research report on Monday, April 24th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, February 27th. Evercore ISI reiterated an “outperform” rating and set a $185.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 19th. Finally, CIBC lifted their price objective on UnitedHealth Group from $186.00 to $187.00 and gave the stock an “outperform” rating in a research report on Monday, April 24th. Two research analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company. The company presently has an average rating of “Buy” and an average price target of $182.65.

In related news, Director Michele J. Hooper sold 15,000 shares of the business’s stock in a transaction on Thursday, March 16th. The stock was sold at an average price of $170.89, for a total transaction of $2,563,350.00. Following the completion of the transaction, the director now directly owns 35,941 shares of the company’s stock, valued at approximately $6,141,957.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP D Ellen Wilson sold 14,000 shares of the business’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the transaction, the executive vice president now directly owns 31,993 shares of the company’s stock, valued at $5,456,086.22. The disclosure for this sale can be found here. Insiders sold a total of 45,148 shares of company stock worth $7,620,249 in the last quarter. Company insiders own 1.65% of the company’s stock. A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Conning Inc. boosted its position in UnitedHealth Group by 0.4% in the third quarter. Conning Inc. now owns 36,075 shares of the healthcare conglomerate’s stock valued at $5,051,000 after buying an additional 160 shares during the last quarter. HL Financial Services LLC boosted its position in UnitedHealth Group by 1.9% in the third quarter. HL Financial Services LLC now owns 13,147 shares of the healthcare conglomerate’s stock valued at $1,841,000 after buying an additional 242 shares during the last quarter. Joel Isaacson & Co. LLC boosted its position in UnitedHealth Group by 4.2% in the third quarter. Joel Isaacson & Co. LLC now owns 3,358 shares of the healthcare conglomerate’s stock valued at $470,000 after buying an additional 136 shares during the last quarter. Commonwealth Equity Services Inc boosted its position in UnitedHealth Group by 0.4% in the third quarter. Commonwealth Equity Services Inc now owns 116,741 shares of the healthcare conglomerate’s stock valued at $16,344,000 after buying an additional 483 shares during the last quarter. Finally, BTC Capital Management Inc. bought a new position in UnitedHealth Group during the third quarter valued at approximately $1,963,000. 86.67% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH) For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment